BMP-2 signaling in ovarian cancer and its association with poor prognosis
Authors:
Open Access
- 14 April 2009
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 2 (1) , 4
Abstract
Background: We previously observed the over-expression of BMP-2 in primary cultures of epithelial ovarian cancer (EOC) cells as compared to normal epithelial cells based on Affymetrix microarray profiling [1]. Here we investigate the effect of BMP-2 on several parameters of ovarian cancer tumorigenesis using the TOV-2223, TOV-1946 and TOV-112D EOC cell lines. Methods: We treated each EOC cell line with recombinant BMP-2 and assayed various parameters associated with tumorigenesis. More specifically, cell signaling events induced by BMP-2 treatment were investigated by western-blot using anti-phosphospecific antibodies. Induction of Id1, Snail and Smad6 mRNA expression was investigated by real time RT-PCR. The ability of cells to migrate was tested using the scratch assay. Cell-cell adhesion was analyzed by the ability of cells to form spheroids. We also investigated BMP-2 expression in tissue samples from a series of EOC patients. Results: Treatment of these cell lines with recombinant BMP-2 induced a rapid phosphorylation of Smad1/5/8 and Erk MAPKs. Increased expression of Id1, Smad6 and Snail mRNAs was also observed. Only in the TOV-2223 cell line were these signaling events accompanied by an alteration in cell proliferation. We also observed that BMP-2 efficiently increased the motility of all three cell lines. In contrast, BMP-2 treatment decreased the ability of TOV-1946 and TOV-112D cell lines to form spheroids indicating an inhibition of cell-cell adhesion. The expression of BMP-2 in tumor tissues from patients was inversely correlated with survival. Conclusion: These results suggest that EOC cell secretion of BMP-2 in the tumor environment contributes to a modification of tumor cell behavior through a change in motility and adherence. We also show that BMP-2 expression in tumor tissues is associated with a poorer prognosis for ovarian cancer patients.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of three new serous epithelial ovarian cancer cell linesBMC Cancer, 2008
- Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC)Molecular Carcinogenesis, 2007
- BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-κB activationJournal of Bone and Mineral Metabolism, 2005
- Bone morphogenetic proteins in melanoma: Angel or devil?Cancer and Metastasis Reviews, 2005
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathwaysOncogene, 2004
- BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cellsBiochemical and Biophysical Research Communications, 2004
- Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cellsOncogene, 2003
- BMP-7-Induced Cell Cycle Arrest of Anaplastic Thyroid Carcinoma Cells via p21CIP1 and p27KIP1Biochemical and Biophysical Research Communications, 2001
- Involvement of ERK in BMP-2 Induced Osteoblastic Differentiation of Mesenchymal Progenitor Cell Line C3H10T1/2Biochemical and Biophysical Research Communications, 2000